Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Molecular & Cellular Oncology Année : 2015

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

Résumé

Rebouissou et al. recently provided preclinical evidence that a subset of patients with muscle-invasive bladder cancer might benefit from anti-epidermal growth factor receptor (EGFR) therapy and reported diagnostic tools for identifying these patients in the clinical setting. This work also identified relevant experimental models that may be useful for future basic and clinical research on this subgroup of tumors.

Dates et versions

hal-01904887 , version 1 (25-10-2018)

Identifiants

Citer

Thierry Lebret, Yann Neuzillet, Nadine Houédé, Sandra Rebouissou, Isabelle Bernard-Pierrot, et al.. Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers. Molecular & Cellular Oncology, 2015, 2 (4), pp.e999507. ⟨10.1080/23723556.2014.999507⟩. ⟨hal-01904887⟩
109 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More